
Sign up to save your podcasts
Or


In this episode of We Know Development™, Timothy Pas, Associate Director, and Laure Descamps, Senior Scientist, from Ardena’s Formulation and Production team, explore how AI can challenge development strategies, help prioritize experiments, and support better decisions in early drug development.
Discover the opportunities, limitations, and scientific expertise behind using AI to move from prediction to practice and from a molecule to a medicine.
What does it take to move innovative science from the lab toward the patient?
In this episode of We Know Development™, Mark van Eldijk, Vice President of Science and Technology at Ardena, discusses nanoparticles, advanced drug development, and the challenges of translating complex technologies into medicines that can make a real impact.
Discover the science, decisions, and expertise behind the journey from nanoparticles to patients.
Welcome to We Know Development™, a podcast from Ardena about the people, decisions, and expertise behind drug development.
Drug development is often described through science, technology, quality, and regulation. All of those are essential. But behind every successful program are people making decisions, navigating uncertainty, solving complex challenges, and building trust.
In We Know Development, we go beyond the science to meet the people shaping drug development and explore what it really takes to move innovative medicines forward.
Subscribe now and join us as we talk with experts, leaders, and innovators from across the drug development journey.
From the publisher's feed